These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 34185313)

  • 61. Use of steroids in COVID-19 patients: A meta-analysis.
    Thakur M; Datusalia AK; Kumar A
    Eur J Pharmacol; 2022 Jan; 914():174579. PubMed ID: 34678244
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Proactive anti-inflammatory therapy with colchicine in the treatment of advanced stages of new coronavirus infection. The first results of the COLORIT study.
    Mareev VY; Orlova YA; Plisyk AG; Pavlikova EP; Akopyan ZA; Matskeplishvili ST; Malakhov PS; Krasnova TN; Seredenina EM; Potapenko AV; Agapov MA; Asratyan DA; Dyachuk LI; Samokhodskaya LM; Mershina ЕА; Sinitsyn VE; Pakhomov PV; Zhdanova EA; Mareev YV; Begrambekova YL; Kamalov АА
    Kardiologiia; 2021 Mar; 61(2):15-27. PubMed ID: 33734043
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Colchicine for Coronary Heart Disease: A Meta-Analysis of Randomized Controlled Trials.
    Chunfeng L; Ping L; Yun Z; Di L; Qi W
    Heart Surg Forum; 2021 Oct; 24(5):E863-E867. PubMed ID: 34623257
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A systematic review of the infectious complications of colchicine and the use of colchicine to treat infections.
    McEwan T; Robinson PC
    Semin Arthritis Rheum; 2021 Feb; 51(1):101-112. PubMed ID: 33360321
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Anti-inflammatory therapy for COVID-19 infection: the case for colchicine.
    Reyes AZ; Hu KA; Teperman J; Wampler Muskardin TL; Tardif JC; Shah B; Pillinger MH
    Ann Rheum Dis; 2021 May; 80(5):550-557. PubMed ID: 33293273
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Ivermectin and mortality in patients with COVID-19: A systematic review, meta-analysis, and meta-regression of randomized controlled trials.
    Zein AFMZ; Sulistiyana CS; Raffaelo WM; Pranata R
    Diabetes Metab Syndr; 2021; 15(4):102186. PubMed ID: 34237554
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Does Asthma Increase the Mortality of Patients with COVID-19?: A Systematic Review and Meta-Analysis.
    Wang Y; Chen J; Chen W; Liu L; Dong M; Ji J; Hu D; Zhang N
    Int Arch Allergy Immunol; 2021; 182(1):76-82. PubMed ID: 32961539
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Differences in Outcomes and Factors Associated With Mortality Among Patients With SARS-CoV-2 Infection and Cancer Compared With Those Without Cancer: A Systematic Review and Meta-analysis.
    Khoury E; Nevitt S; Madsen WR; Turtle L; Davies G; Palmieri C
    JAMA Netw Open; 2022 May; 5(5):e2210880. PubMed ID: 35532936
    [TBL] [Abstract][Full Text] [Related]  

  • 69. SARS-CoV-2 infection during pregnancy and risk of preeclampsia: a systematic review and meta-analysis.
    Conde-Agudelo A; Romero R
    Am J Obstet Gynecol; 2022 Jan; 226(1):68-89.e3. PubMed ID: 34302772
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis.
    ; Sterne JAC; Murthy S; Diaz JV; Slutsky AS; Villar J; Angus DC; Annane D; Azevedo LCP; Berwanger O; Cavalcanti AB; Dequin PF; Du B; Emberson J; Fisher D; Giraudeau B; Gordon AC; Granholm A; Green C; Haynes R; Heming N; Higgins JPT; Horby P; Jüni P; Landray MJ; Le Gouge A; Leclerc M; Lim WS; Machado FR; McArthur C; Meziani F; Møller MH; Perner A; Petersen MW; Savovic J; Tomazini B; Veiga VC; Webb S; Marshall JC
    JAMA; 2020 Oct; 324(13):1330-1341. PubMed ID: 32876694
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Sequential doxycycline and colchicine combination therapy in Covid-19: The salutary effects.
    Al-Kuraishy HM; Al-Gareeb AI; Qusty N; Cruz-Martins N; El-Saber Batiha G
    Pulm Pharmacol Ther; 2021 Apr; 67():102008. PubMed ID: 33727066
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The effect of tocilizumab on COVID-19 patient mortality: A systematic review and meta-analysis of randomized controlled trials.
    Lin WT; Hung SH; Lai CC; Wang CY; Chen CH
    Int Immunopharmacol; 2021 Jul; 96():107602. PubMed ID: 33812260
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Potential Role of Colchicine in Combating COVID-19 Cytokine Storm and Its Ability to Inhibit Protease Enzyme of SARS-CoV-2 as Conferred by Molecular Docking Analysis.
    Kamel NA; Ismail NSM; Yahia IS; Aboshanab KM
    Medicina (Kaunas); 2021 Dec; 58(1):. PubMed ID: 35056328
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Colchicine and risk of hospitalization due to COVID-19: A population-based study.
    Sáenz-Aldea M; Salgado-Barreira Á; Taracido Trunk M; Piñeiro-Lamas M; Herdeiro MT; Portela-Romero M; Saez M; Figueiras A
    J Med Virol; 2023 Feb; 95(2):e28496. PubMed ID: 36639903
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Janus kinase inhibitors for the treatment of COVID-19.
    Kramer A; Prinz C; Fichtner F; Fischer AL; Thieme V; Grundeis F; Spagl M; Seeber C; Piechotta V; Metzendorf MI; Golinski M; Moerer O; Stephani C; Mikolajewska A; Kluge S; Stegemann M; Laudi S; Skoetz N
    Cochrane Database Syst Rev; 2022 Jun; 6(6):CD015209. PubMed ID: 35695334
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Fluvoxamine in Nonhospitalized Patients With Acute COVID-19 Infection and the Lack of Efficacy in Reducing Rates of Hospitalization, Mechanical Ventilation, and Mortality in Placebo-Controlled Trials: A Systematic Review and Meta-Analysis.
    Bhuta S; Khokher W; Kesireddy N; Iftikhar S; Beran A; Mhanna M; Patel NJ; Patel M; Burmeister C; Assaly R
    Am J Ther; 2022 May-Jun 01; 29(3):e298-e304. PubMed ID: 35383578
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Interventions for treatment of COVID-19: A living systematic review with meta-analyses and trial sequential analyses (The LIVING Project).
    Juul S; Nielsen EE; Feinberg J; Siddiqui F; Jørgensen CK; Barot E; Nielsen N; Bentzer P; Veroniki AA; Thabane L; Bu F; Klingenberg S; Gluud C; Jakobsen JC
    PLoS Med; 2020 Sep; 17(9):e1003293. PubMed ID: 32941437
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study.
    Bartoletti M; Marconi L; Scudeller L; Pancaldi L; Tedeschi S; Giannella M; Rinaldi M; Bussini L; Valentini I; Ferravante AF; Potalivo A; Marchionni E; Fornaro G; Pascale R; Pasquini Z; Puoti M; Merli M; Barchiesi F; Volpato F; Rubin A; Saracino A; Tonetti T; Gaibani P; Ranieri VM; Viale P; Cristini F;
    Clin Microbiol Infect; 2021 Jan; 27(1):105-111. PubMed ID: 32971254
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Efficacy and safety of current medications for treating severe and non-severe COVID-19 patients: an updated network meta-analysis of randomized placebo-controlled trials.
    Cheng Q; Chen J; Jia Q; Fang Z; Zhao G
    Aging (Albany NY); 2021 Sep; 13(18):21866-21902. PubMed ID: 34531332
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Corticosteroid therapy for COVID-19: A systematic review and meta-analysis of randomized controlled trials.
    Pulakurthi YS; Pederson JM; Saravu K; Gupta N; Balasubramanian P; Kamrowski S; Schmidt M; Vegivinti CTR; Dibas M; Reierson NL; Pisipati S; Joseph BA; Selvan PT; Dmytriw AA; Keesari PR; Sriram V; Chittajallu S; Brinjikji W; Katamreddy RR; Chibbar R; Davis AR; Malpe M; Mishra HK; Kallmes KM; Hassan AE; Evanson KW
    Medicine (Baltimore); 2021 May; 100(20):e25719. PubMed ID: 34011029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.